Canntab Therapeutics Limited
CTABF · OTC
5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $691 | $1,491 | $2,090 | $414 |
| Short-Term Investments | $0 | $0 | $0 | $1,175 |
| Receivables | $210 | $207 | $38 | $240 |
| Inventory | $489 | $1,721 | $906 | $0 |
| Other Curr. Assets | $75 | $96 | $451 | $75 |
| Total Curr. Assets | $1,465 | $3,515 | $3,485 | $1,904 |
| Property Plant & Equip (Net) | $1,084 | $2,557 | $1,772 | $343 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $304 | $289 | $252 | $180 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $167 |
| Total NC Assets | $1,387 | $2,846 | $2,024 | $689 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,852 | $6,361 | $5,509 | $2,593 |
| Liabilities | – | – | – | – |
| Payables | $161 | $1,015 | $962 | $51 |
| Short-Term Debt | $1,513 | $244 | $202 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $129 | $41 | $0 | $40 |
| Other Curr. Liab. | $755 | $365 | $252 | $141 |
| Total Curr. Liab. | $2,558 | $1,665 | $1,416 | $232 |
| LT Debt | $328 | $1,322 | $524 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $93 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $278 | $1,105 | $0 | $0 |
| Total NC Liab. | $606 | $2,427 | $564 | $93 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $354 | $538 | $686 | $0 |
| Total Liabilities | $3,163 | $4,092 | $1,980 | $326 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13,443 | $11,606 | $9,844 | $6,554 |
| Retained Earnings | -$16,699 | -$13,010 | -$8,590 | -$5,983 |
| AOCI | $0 | $814 | $0 | $0 |
| Other Equity | $2,945 | $2,859 | $2,275 | $1,697 |
| Total Equity | -$311 | $2,269 | $3,529 | $2,268 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,852 | $6,361 | $5,509 | $2,593 |
| Net Debt | $1,149 | $75 | -$1,364 | -$414 |